Health
Expert panel provides guidance for optimized design of early drug trials for Alzheimer’s, related dementias – News-Medical.Net
An expert panel convened by the Alzheimer’s Drug Discovery Foundation (ADDF) and The Association for Frontotemporal Degeneration (AFTD) provides guidance on best…
An expert panel convened by the Alzheimer’s Drug Discovery Foundation (ADDF) and The Association for Frontotemporal Degeneration (AFTD) provides guidance on best practices for the design of early drug trials for Alzheimer’s disease, frontotemporal degeneration (FTD), and other neurodegenerative dementias. Their guidance was published in the May 18, 2021 issue of Neurology®, the medical journal of the American Academy of Neurology (“Value-Generating Exploratory Trials in Neurodegenerative Dementias”).
…
-
General20 hours agoYoung boy flown to Brisbane hospital after K’gari dingo attack
-
General18 hours agoBritish and US planes fly 12-hour mission to patrol Russian border
-
Noosa News21 hours agoWarm weather could make way for rain with ‘damaging winds, large hail’
-
General6 hours agoByford rail extension opening marks final stage of Perth Metronet